Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons

PLoS Pathogens

Volumn 12, Issue 5, 2016, Pages

  Deriu, Elisa ^a   Boxx, Gayle M ^a   He, Xuesong ^a   Pan, Calvin ^b   Benavidez, Sammy David ^a   Cen, Lujia ^a   Rozengurt, Nora ^b   Shi, Wenyuan ^a   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES MICROFLORA; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; WESTERN BLOTTING; ANIMAL; ANIMAL SALMONELLOSIS; C57BL MOUSE; COMPLICATION; DISEASE MODEL; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; MIXED INFECTION; ORTHOMYXOVIRUS INFECTION;

ANIMALS; COINFECTION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MICROBIOME; IMMUNOBLOTTING; INTERFERON TYPE I; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; SALMONELLA INFECTIONS, ANIMAL;

EID: 84973343725     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005572     Document Type: Article

References (68)

1. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009;119(7):1910–20. Epub 2009/06/03. doi: 10.1172/JCI3541219487810; PubMed Central PMCID: PMC2701856.
2. Fensterl V, Sen GC, Interferons and viral infections. Biofactors. 2009;35(1):14–20. Epub 2009/03/26. doi: 10.1002/biof.619319841.
3. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 2002;17(3):251–63. Epub 2002/10/02. 12354379.
4. Tough DF, Borrow P, Sprent J, Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272(5270):1947–50. Epub 1996/06/28. 8658169.
5. Schneider WM, Chevillotte MD, Rice CM, Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513–45. Epub 2014/02/22. doi: 10.1146/annurev-immunol-032713-12023124555472; PubMed Central PMCID: PMC4313732.
6. Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z, Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med. 2014;211(12):2397–410. Epub 2014/11/05. doi: 10.1084/jem.2014062525366965; PubMed Central PMCID: PMC4235643.
7. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–4. Epub 2008/12/02. doi: 10.1038/nature0754019043404; PubMed Central PMCID: PMC2677729.
8. Round JL, Mazmanian SK, Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204–9. Epub 2010/06/23. doi: 10.1073/pnas.090912210720566854; PubMed Central PMCID: PMC2901479.
9. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–98. Epub 2009/10/20. doi: 10.1016/j.cell.2009.09.03319836068; PubMed Central PMCID: PMC2796826.
10. Scales BS, Huffnagle GB, The microbiome in wound repair and tissue fibrosis. J Pathol. 2013;229(2):323–31. Epub 2012/10/09. doi: 10.1002/path.411823042513; PubMed Central PMCID: PMC3631561.
11. Pfefferle PI, Renz H, The mucosal microbiome in shaping health and disease. F1000Prime Rep. 2014;6:11. Epub 2014/03/05. doi: 10.12703/P6-1124592323; PubMed Central PMCID: PMC3914505.
12. Round JL, Mazmanian SK, The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–23. Epub 2009/04/04. doi: 10.1038/nri251519343057; PubMed Central PMCID: PMC4095778.
13. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007;131(1):33–45. Epub 2007/10/10. doi: 10.1016/j.cell.2007.08.01717923086; PubMed Central PMCID: PMC2169385.
14. Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339(6120):708–11. Epub 2013/02/09. doi: 10.1126/science.123246723393266; PubMed Central PMCID: PMC4004111.
15. Dilantika C, Sedyaningsih ER, Kasper MR, Agtini M, Listiyaningsih E, Uyeki TM, et al. Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis. 2010;10:3. Epub 2010/01/08. doi: 10.1186/1471-2334-10-320053294; PubMed Central PMCID: PMC2820480.
16. Zheng D, Limmon GV, Yin L, Leung NH, Yu H, Chow VT, et al. A cellular pathway involved in Clara cell to alveolar type II cell differentiation after severe lung injury. PLoS One. 2013;8(8):e71028. doi: 10.1371/journal.pone.007102823940685; PubMed Central PMCID: PMCPMC3734298.
17. Yin L, Xu S, Cheng J, Zheng D, Limmon GV, Leung NH, et al. Spatiotemporal quantification of cell dynamics in the lung following influenza virus infection. J Biomed Opt. 2013;18(4):046001. doi: 10.1117/1.JBO.18.4.04600123545853.
18. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 2010;467(7314):426–9. Epub 2010/09/25. doi: 10.1038/nature0941520864996; PubMed Central PMCID: PMC2946174.
19. Peterson DA, Frank DN, Pace NR, Gordon JI, Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008;3(6):417–27. Epub 2008/06/11. doi: 10.1016/j.chom.2008.05.00118541218; PubMed Central PMCID: PMC2872787.
20. Mattei F, Schiavoni G, Belardelli F, Tough DF, IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol. 2001;167(3):1179–87. Epub 2001/07/24. 11466332.
21. Tian X, Xu F, Lung WY, Meyerson C, Ghaffari AA, Cheng G, et al. Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria. PLoS One. 2012;7(9):e41879. Epub 2012/09/11. doi: 10.1371/journal.pone.004187922962579; PubMed Central PMCID: PMC3433467.
22. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71(5):2839–58. Epub 2003/04/22. 12704158; PubMed Central PMCID: PMC153285.
23. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014;40(2):262–73. Epub 2014/02/11. doi: 10.1016/j.immuni.2014.01.00324508234; PubMed Central PMCID: PMC3964146.
24. Liu JZ, Jellbauer S, Poe AJ, Ton V, Pesciaroli M, Kehl-Fie TE, et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe. 2012;11(3):227–39. Epub 2012/03/20. doi: 10.1016/j.chom.2012.01.01722423963; PubMed Central PMCID: PMC3308348.
25. Nairz M, Fritsche G, Brunner P, Talasz H, Hantke K, Weiss G, Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol. 2008;38(7):1923–36. Epub 2008/06/27. doi: 10.1002/eji.20073805618581323.
26. Spees AM, Kingsbury DD, Wangdi T, Xavier MN, Tsolis RM, Baumler AJ, Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium colitis. Infect Immun. 2014;82(4):1692–7. Epub 2014/01/15. doi: 10.1128/IAI.01508-1324421037; PubMed Central PMCID: PMC3993401.
27. Harrington L, Srikanth CV, Antony R, Shi HN, Cherayil BJ, A role for natural killer cells in intestinal inflammation caused by infection with Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol. 2007;51(2):372–80. doi: 10.1111/j.1574-695X.2007.00313.x17727655; PubMed Central PMCID: PMCPMC3205980.
28. Rhee SJ, Walker WA, Cherayil BJ, Developmentally regulated intestinal expression of IFN-gamma and its target genes and the age-specific response to enteric Salmonella infection. J Immunol. 2005;175(2):1127–36. 16002714.
29. Ramarathinam L, Shaban RA, Niesel DW, Klimpel GR, Interferon gamma (IFN-gamma) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb Pathog. 1991;11(5):347–56. 1816488.
30. Nauciel C, Espinasse-Maes F, Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun. 1992;60(2):450–4. 1730475; PubMed Central PMCID: PMCPMC257648.
31. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science. 2008;319(5865):962–5. Epub 2008/02/16. doi: 10.1126/science.115244918276893.
32. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917–21. Epub 2004/11/09. doi: 10.1038/nature0310415531878.
33. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, et al. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe. 2013;14(1):26–37. Epub 2013/07/23. doi: 10.1016/j.chom.2013.06.00723870311; PubMed Central PMCID: PMC3752295.
34. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W, Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75(2):263–74. Epub 1993/10/22. 8402911.
35. Rennick DM, Fort MM, Davidson NJ, Studies with IL-10-/- mice: an overview. J Leukoc Biol. 1997;61(4):389–96. Epub 1997/04/01. 9103224.
36. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006;131(1):117–29. Epub 2006/07/13. doi: 10.1053/j.gastro.2006.04.02016831596.
37. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. 2013;342(6157):447–53. Epub 2013/09/28. doi: 10.1126/science.123791024072822; PubMed Central PMCID: PMC4005805.
38. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A, Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103. Epub 2015/01/24. doi: 10.1038/nri378725614319.
39. Ishihara T, Aga M, Hino K, Ushio C, Taniguchi M, Iwaki K, et al. Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed Res. 2005;26(4):179–85. Epub 2005/09/13. 16152734.
40. Plumlee CR, Lee C, Beg AA, Decker T, Shuman HA, Schindler C, Interferons direct an effective innate response to Legionella pneumophila infection. J Biol Chem. 2009;284(44):30058–66. Epub 2009/09/02. doi: 10.1074/jbc.M109.01828319720834; PubMed Central PMCID: PMC2781560.
41. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466(7309):973–7. Epub 2010/08/21. doi: 10.1038/nature0924720725040; PubMed Central PMCID: PMC3492754.
42. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med. 2004;200(4):437–45. Epub 2004/08/11. doi: 10.1084/jem.2004071215302901; PubMed Central PMCID: PMC2211937.
43. Kawashima T, Kosaka A, Yan H, Guo Z, Uchiyama R, Fukui R, et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-beta. Immunity. 2013;38(6):1187–97. Epub 2013/06/25. doi: 10.1016/j.immuni.2013.02.02423791646.
44. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–5. Epub 2007/08/19. doi: 10.1073/pnas.070662510417699621; PubMed Central PMCID: PMC1959459.
45. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra91. Epub 2013/07/12. doi: 10.1126/scitranslmed.300643823843452; PubMed Central PMCID: PMC4094294.
46. Hohmann EL, Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263–9. doi: 10.1086/31845711170916.
47. Sing A, Merlin T, Knopf HP, Nielsen PJ, Loppnow H, Galanos C, et al. Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun. 2000;68(3):1600–7. 10678979; PubMed Central PMCID: PMCPMC97320.
48. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S, Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol. 2012;13(10):954–62. Epub 2012/08/28. doi: 10.1038/ni.239722922364; PubMed Central PMCID: PMC4005791.
49. Gordon MA, Jack DL, Dockrell DH, Lee ME, Read RC, Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses. Infect Immun. 2005;73(6):3445–52. Epub 2005/05/24. doi: 10.1128/IAI.73.6.3445–3452.200515908373; PubMed Central PMCID: PMC1111838.
50. Broz P, Ohlson MB, Monack DM, Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes. 2012;3(2):62–70. doi: 10.4161/gmic.1914122198618; PubMed Central PMCID: PMCPMC3370950.
51. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203(10):2271–9. Epub 2006/09/20. doi: 10.1084/jem.2006130816982811; PubMed Central PMCID: PMC2118116.
52. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA, et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009;5(5):476–86. Epub 2009/05/21. doi: 10.1016/j.chom.2009.03.01119454351; PubMed Central PMCID: PMC2768556.
53. Devireddy LR, Teodoro JG, Richard FA, Green MR, Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 2001;293(5531):829–34. Epub 2001/08/04. doi: 10.1126/science.106107511486081.
54. Li C, Chen H, Ding F, Zhang Y, Luo A, Wang M, et al. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem J. 2009;422(2):363–72. Epub 2009/06/19. doi: 10.1042/BJ2009046519534726.
55. Schroll A, Eller K, Feistritzer C, Nairz M, Sonnweber T, Moser PA, et al. Lipocalin-2 ameliorates granulocyte functionality. Eur J Immunol. 2012;42(12):3346–57. Epub 2012/09/12. doi: 10.1002/eji.20114235122965758.
56. Simard JC, Girard D, Tessier PA, Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism. J Leukoc Biol. 2010;87(5):905–14. Epub 2010/01/28. doi: 10.1189/jlb.100967620103766.
57. Santos RL, Raffatellu M, Bevins CL, Adams LG, Tukel C, Tsolis RM, et al. Life in the inflamed intestine, Salmonella style. Trends Microbiol. 2009;17(11):498–506. Epub 2009/10/13. doi: 10.1016/j.tim.2009.08.00819819699; PubMed Central PMCID: PMC3235402.
58. Lee KS, Jeong ES, Heo SH, Seo JH, Jeong DG, Choi YK, IL-10 suppresses bactericidal response of macrophages against Salmonella Typhimurium. J Microbiol. 2011;49(6):1050–3. Epub 2011/12/29. doi: 10.1007/s12275-011-1043-z22203573.
59. Pie S, Matsiota-Bernard P, Truffa-Bachi P, Nauciel C, Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Infect Immun. 1996;64(3):849–54. 8641791; PubMed Central PMCID: PMCPMC173847.
60. Nikolaus S, Rutgeerts P, Fedorak R, Steinhart AH, Wild GE, Theuer D, et al. Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut. 2003;52(9):1286–90. Epub 2003/08/13. 12912859; PubMed Central PMCID: PMC1773804.
61. Musch E, Andus T, Malek M, Chrissafidou A, Schulz M, Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta—an open long-term trial. Z Gastroenterol. 2007;45(12):1235–40. Epub 2007/12/15. doi: 10.1055/s-2007-96337818080224.
62. Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J, Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol. 1996;40(4):618–27. Epub 1996/10/01. doi: 10.1002/ana.4104004128871582.
63. Billiau A, Anti-inflammatory properties of Type I interferons. Antiviral Res. 2006;71(2–3):108–16. Epub 2006/04/22. doi: 10.1016/j.antiviral.2006.03.00616626815.
64. Stojiljkovic I, Baumler AJ, Heffron F, Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. J Bacteriol. 1995;177(5):1357–66. Epub 1995/03/01. 7868611; PubMed Central PMCID: PMC176743.
65. Prentki P, Krisch HM, In vitro insertional mutagenesis with a selectable DNA fragment. Gene. 1984;29(3):303–13. Epub 1984/09/01. 6237955.
66. Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL, Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp. 2011;(51). doi: 10.3791/270221587154; PubMed Central PMCID: PMCPMC3280633.
67. Li Y, Ku CY, Xu J, Saxena D, Caufield PW, Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J Dent Res. 2005;84(6):559–64. Epub 2005/05/26. 15914595.
68. Sheffield VC, Cox DR, Lerman LS, Myers RM, Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A. 1989;86(1):232–6. Epub 1989/01/01. 2643100; PubMed Central PMCID: PMC286438.